INEOS Inovyn (London, U.K.) has confirmed an agreement to acquire the remaining 50% shareholding in Runcorn MCP Limited, together with the assets and employees associated with ethylene dichloride (EDC) production at Runcorn, from Vynova Runcorn Limited, following its entry into administration in 2025. The acquisition remains subject to the completion of the necessary legal and regulatory processes and is expected to complete later in 2026.
The transaction will fully integrate the chlor-alkali and EDC value chain under INEOS Inovyn (London, U.K.). By bringing these businesses together, INEOS Inovyn will strengthen the long-term future of the site and enhance security of supply for customers.
Around 98% of the chlorine used in drinking water treatment in the U.K. is supplied by Runcorn, highlighting the site’s critical importance to public health and national infrastructure.
The acquisition represents an important step in safeguarding the continuity of strategically critical chlor-alkali operations in the U.K. These products are essential for water treatment and food manufacturing and support a wide range of industries, including pharmaceuticals, healthcare, and construction. Strengthening the U.K.’s chlor-alkali backbone is vital for strategic autonomy and national resilience.